BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24913710)

  • 21. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.
    Dai D; Dong XH; Cheng ST; Zhu G; Guo XL
    Tumour Biol; 2014 Aug; 35(8):8209-16. PubMed ID: 24850174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical characteristics of 681 patients with diffuse large B-cell lymphoma].
    Wen JJ; Liu ZB; Xu J; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1004-9. PubMed ID: 23363791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
    Paydas S; Ergin M; Erdogan S; Seydaoglu G
    Leuk Res; 2008 Sep; 32(9):1424-30. PubMed ID: 18282597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.
    Gao X; Li J; Wang Y; Liu S; Yue B
    PLoS One; 2018; 13(6):e0199398. PubMed ID: 29920566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.
    Gu X; Xue JQ; Zhu X; Ye MS; Zhang WH
    Tumour Biol; 2014 Sep; 35(9):9395-404. PubMed ID: 24952891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
    Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Olsen ML; Funder AM; d'Amore F
    Leuk Lymphoma; 2007 Mar; 48(3):584-95. PubMed ID: 17454603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis.
    Li Q; Liu Y; Zhang HM; Huang YP; Wang TY; Li DS; Sun HZ
    Gastroenterol Res Pract; 2014; 2014():827989. PubMed ID: 25614737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between vascular endothelial growth factor expression and lymph node metastasis in cervical cancer: A meta-analysis.
    Sun H; Tang F; Zhou S; Li X; Wang S; Huang K; Jia Y; Tian X; Ma D; Li S
    J Obstet Gynaecol Res; 2016 Oct; 42(10):1310-1316. PubMed ID: 27334572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.
    Zhang J; Chen B; Xu X
    Leuk Lymphoma; 2014 Mar; 55(3):509-14. PubMed ID: 23741977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis.
    He X; Chen Z; Fu T; Jin X; Yu T; Liang Y; Zhao X; Huang L
    BMC Cancer; 2014 Mar; 14():153. PubMed ID: 24597851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
    Huang H; Fan L; Fu D; Lin Q; Shen J
    Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of PGR genetic polymorphisms to the pathogenesis of endometrial cancer: A meta-analysis.
    Chen Z; Wang SH; Zhou J; Wu T; Li J
    J Cancer Res Ther; 2015; 11(4):810-7. PubMed ID: 26881523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab.
    Powell JR; Dojcinov S; King L; Wosniak S; Gerry S; Casbard A; Bailey H; Gallop-Evans E; Maughan T
    Leuk Lymphoma; 2013 May; 54(5):959-66. PubMed ID: 23020605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma.
    Hou Y; Wang HQ; Ba Y
    Med Oncol; 2012 Dec; 29(5):3498-503. PubMed ID: 22528513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of microRNA-224 in Various Cancers: A Meta-analysis.
    Zhang Y; Guo CC; Guan DH; Yang CH; Jiang YH
    Arch Med Res; 2017 Jul; 48(5):472-482. PubMed ID: 29133193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis.
    Wang D; Guo XZ; Li HY; Zhao JJ; Shao XD; Wu CY
    Tumour Biol; 2014 Oct; 35(10):10301-7. PubMed ID: 25034525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
    Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of CD40 in diffuse large B-cell lymphoma].
    Wang S; Wang YP; Hao YY; Zheng Y
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):819-23. PubMed ID: 24507100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse prognostic impact of vascular endothelial growth factor gene polymorphisms in patients with diffuse large B-cell lymphoma.
    Yoon KA; Kim MK; Eom HS; Lee H; Park WS; Sohn JY; Kim MJ; Kong SY
    Leuk Lymphoma; 2017 Nov; 58(11):2677-2682. PubMed ID: 28326867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.